Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Breast Cancer Research is Scopus-indexed (Q1, CiteScore 8.1), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1465-5411Verify ISSN ↗1465-542XVerify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 73 / 428 | 83rd | Q1 |
| Cancer Research | 63 / 233 | 73rd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 1999–present, best quartile Q1, CiteScore 8.1.
Breast Cancer Research is Q1 in Oncology (rank 73 of 428) and Q2 in Cancer Research (rank 63 of 233), by CiteScore 2025.
Breast Cancer Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.1, which places it in quartile Q1 at the 83rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.907, quartile Q1, with an H-index of 186.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$4,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Breast Cancer Research is published by BioMed Central Ltd. Its print ISSN is 1465-5411 and its online ISSN is 1465-542X.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Breast Cancer Research has an h-index of 210 and a 2-year mean of 5.53 citations per paper (OpenAlex). Its Scopus CiteScore is 8.1, quartile Q1. On 2-year citations it ranks #47 of 424 Scopus journals in Oncology.
Breast Cancer Research published 249 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from China (26%), United States (22.3%) and Spain (7.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 14 retracted papers are recorded (2.4 per 1,000 papers). The Problematic Paper Screener flags 5 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.